These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28137206)

  • 1. Biopsy-Proven BK Virus-Associated Nephropathy: Clinico-Pathologic Correlations.
    Jahdali S; Al Oudah N; Alsaad KO; Kfoury H; Qurashi S; Al Sayyari A
    Exp Clin Transplant; 2017 Jun; 15(3):289-294. PubMed ID: 28137206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Hepatitis C-Positive Kidney Transplant Recipients Compared With Hepatitis C-Negative Recipients in Today's Era of Immunosuppression: A UNOS Database Analysis With Long-Term Follow-Up.
    Khalil A; Mujtaba MA; Aljanabi OT; Ghabril MS; Taber TE; Yaqub MS; Sharfuddin A
    Exp Clin Transplant; 2017 Jun; 15(3):282-288. PubMed ID: 27310008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
    Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
    Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
    Halim MA; Al-Otaibi T; Gheith O; Zkaria Z; Mosaad A; Said T; Nair P; Nampoory N
    Exp Clin Transplant; 2014 Dec; 12(6):528-33. PubMed ID: 25489803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
    Mohamed M; Parajuli S; Muth B; Astor BC; Panzer SE; Mandelbrot D; Zhong W; Djamali A
    Transpl Infect Dis; 2016 Jun; 18(3):361-71. PubMed ID: 26998753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
    Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
    Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for BK Viremia/Viruria and the Impact of Management of BK Virus Nephropathy in Renal Transplant Recipients.
    Zakaria ZE; Elokely AM; Ghorab AA; Bakr AI; Halim MA; Gheith OA; Nagib AM; Makkeyah Y; Balaha MA; Magdy MM; Al-Otaibi T
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):83-91. PubMed ID: 30777529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year.
    Wojciechowski D; Chanda R; Chandran S; Lee B; Webber A; Macaraig M; Tomlanovich S; Vincenti F
    Transplantation; 2012 Dec; 94(11):1117-23. PubMed ID: 23060281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low prevalence of BK virus nephropathy on nonprotocol renal biopsies in Iranian kidney transplant recipients: one center's experience and review of the literature.
    Soleymanian T; Rasulzadegan MH; Sotoodeh M; Ganji MR; Naderi G; Amin M; Saddadi F; Hakemi M; Najafi I
    Exp Clin Transplant; 2010 Dec; 8(4):297-302. PubMed ID: 21143095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients.
    Lee HM; Jang IA; Lee D; Kang EJ; Choi BS; Park CW; Choi YJ; Yang CW; Kim YS; Chung BH
    Korean J Intern Med; 2015 Nov; 30(6):865-72. PubMed ID: 26552462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors and outcome in BK virus nephropathy in a Hispanic kidney transplant population.
    Pérez-Torres D; Bertrán-Pasarell J; Santiago-Delpín E; González-Ramos M; Medina-Mangual S; Morales-Otero L; González-Caraballo Z
    Transpl Infect Dis; 2010 Feb; 12(1):16-22. PubMed ID: 19804584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of BK virus infection and nephropathy during the first year after kidney transplantation.
    Soleymanian T; Keyvani H; Jazayeri SM; Fazeli Z; Ghamari S; Mahabadi M; Chegeni V; Najafi I; Ganji MR
    Iran J Kidney Dis; 2014 Mar; 8(2):145-51. PubMed ID: 24685738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal serum creatinine increase and exacerbation of tubulointerstitial inflammation during the first two months in resolving polyomavirus BK nephropathy.
    Masutani K; Tsuchimoto A; Matsukuma Y; Kurihara K; Nishiki T; Kitada H; Tanaka M; Kitazono T; Tsuruya K
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():45-50. PubMed ID: 26031586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BK polyomavirus infection after renal transplantation: Surveillance in a resource-challenged setting.
    Bagchi S; Gopalakrishnan V; Srivastava SK; Upadhayay A; Singh G; Bhowmik D; Mahajan S; Dinda A; Agarwal SK
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28834032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of BK virus nephropathy in kidney transplant recipients at the Royal Hospital - Clinical Audit - Oman.
    Al-Raisi F; Mohsin N; Kamble P
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():156-8. PubMed ID: 25894146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human leukocyte antigen Cw7-mediated protection against polyoma BK virus in renal transplant recipients who received grafts from antigen-positive donors.
    Gheith O; Al-Otaibi T; Zakaria Z; Abdel Halim M; Nampoory N
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():383-7. PubMed ID: 25894195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do Antithymocyte Globulin-Free Acute Rejection Therapies Increase the Risk of Polyoma Nephropathy in Renal Transplant Recipients?
    Günay E; Zeytinoğlu A; Şen S; Yılmaz M; Atay G; Aşcı G; Sezer TO; Töz H
    Transplant Proc; 2019 May; 51(4):1112-1114. PubMed ID: 31101182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
    Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
    Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
    Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
    Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.